BioXcel Therapeutics (BTAI) Interest Coverage Ratio Growth (1y) (2020 - 2026)
BioXcel Therapeutics (BTAI) Interest Coverage Ratio Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -14.04% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 73.06% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -13.48% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -21.30% |
| 10 | BioXcel Therapeutics | 25.46 Mn | 25.46 Mn | -77,000.00 | -9.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.36% |
| Dec 31, 2025 | 15.07% |
| Sep 30, 2025 | 19.37% |
| Jun 30, 2025 | 13.73% |
| Mar 31, 2025 | 62.25% |
| Dec 31, 2024 | 56.66% |
| Sep 30, 2024 | 75.98% |
| Jun 30, 2024 | 73.42% |
| Mar 31, 2024 | 60.30% |
| Dec 31, 2023 | 58.46% |
| Sep 30, 2023 | -50.07% |
| Jun 30, 2023 | 37.06% |
| Mar 31, 2023 | 99.62% |
| Dec 31, 2022 | 99.65% |
| Sep 30, 2022 | 99.54% |
| Jun 30, 2022 | 98.34% |
| Mar 31, 2022 | -19.34% |
| Dec 31, 2021 | 17.43% |
| Sep 30, 2021 | 50.79% |
| Jun 30, 2021 | 3.38% |